Sanuwave Health, Inc. SNWV 深 沪
等待开盘 09-19 09:30:00 美东时间
35.09
-0.340
-0.96%
华盛通- 最 高36.20
- 今 开35.70
- 成交量 4.98万股
- 最 低 34.5534
- 昨 收 35.43
- 总市值 3.01亿
- 52周最高 46.585
- 市盈率 静 --
- 换手率 0.58%
- 52周最低 24.80
- 委 比 12.47%
- 总股本 856.80万
- 历史最高 46.585
- 量 比 1.38
- 振 幅 4.65%
- 历史最低 24.80
- 每 手 1
- 风险率
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多美股大行评级 | 潜在涨幅403.28%！瑞杰金融首予Kalaris Therapeutics"强烈买入"评级，目标价23美元
今日重点评级关注：花旗：维持Ionis Pharmaceuticals"买入"评级，目标价从69美元升至84美元；Melius Research：上调康明斯评级至"买入"，目标价500美元
09-04 09:49
Northland Capital Markets Initiates Coverage On SANUWAVE Health with Outperform Rating, Announces Price Target of $55
Northland Capital Markets analyst Carl Byrnes initiates coverage on SANUWAVE Health (NASDAQ:SNWV) with a Outperform rating and announces Price Target of $55.
09-04 02:13
美股大行评级 | 英伟达、Snowflake、万国数据、沃尔玛、Target等均获大行上调目标价
今日重点评级关注：杰富瑞：维持aTyr Pharma"买入"评级，目标价从9美元升至17美元；花旗：维持Ionis制药"买入"评级，目标价从65美元升至69美元
08-25 08:34
Sanuwave Health rises after $5M payment related to patent sale
Sanuwave (NASDAQ:SNWV) shares rose after it announced that it has received a $5M cash payment from its third-party licensee in connection with the exercise of a previously granted acquisition option. ...
08-23 03:11
Roth Capital Maintains Buy on SANUWAVE Health, Raises Price Target to $55
Roth Capital analyst Kyle Bauser maintains SANUWAVE Health (NASDAQ:SNWV) with a Buy and raises the price target from $54 to $55.
08-23 01:19
Sanuwave Receives $5M from Patent Acquisition
Sanuwave Health ( ($SNWV) ) has provided an announcement. Sanuwave, Inc. entere...
08-22 04:56
Sanuwave Health Stockholders Approve Key Proposals
An announcement from Sanuwave Health ( ($SNWV) ) is now available. On August 19...
08-21 05:20
Sanuwave Health Reports Record Q2 Revenue Growth
SANUWAVE Health Inc. ( ($SNWV) ) has released its Q2 earnings. Here is a breakd...
08-09 12:17
SANUWAVE Health Affirms FY2025 Sales Guidance of $48M-$50M Vs. $47.05M Est.
Financial OutlookThe Company forecasts Q3 2025 revenue of $12-$12.7 million and reiterates full year 2025 revenue guidance of $48-$50 million (47-53% increase as compared to full year 2024 revenue).
08-08 18:11
Earnings Scheduled For August 7, 2025
Companies Reporting Before The Bell • GoHealth (NASDAQ:GOCO) is estimated to re...
08-07 16:33
